Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1

B H Jiang1, G Jiang, J Z Zheng

  • 1Department of Molecular and Experimental Medicine, BCC239, The Scripps Research Institute, La Jolla, California 92037, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|July 18, 2001
PubMed

Insights

The phosphatidylinositol 3-kinase (PI3K) pathway upregulates hypoxia-inducible factor-1alpha (HIF-1alpha) protein, not mRNA, in cancer cells. This PI3K-dependent increase in HIF-1alpha is linked to cancer growth and can be targeted.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The phosphatidylinositol 3-kinase (PI3K) pathway is frequently dysregulated in human cancers.
  • Up-regulation of PI3K signaling can occur through mutations in PI3K, Akt, or loss of the tumor suppressor PTEN.
  • The full impact of PI3K pathway activation on cancer biology remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between PI3K signaling and hypoxia-inducible factor (HIF) expression in cancer cells.
  • To determine whether PI3K pathway activation specifically affects HIF-1alpha protein or mRNA levels.
  • To explore the role of PI3K signaling in regulating vascular endothelial growth factor (VEGF) expression.

Main Methods:

  • Utilized human cancer cell lines (PC-3, DU145) with varying PI3K pathway activity.
  • Administered growth factors (insulin, epidermal growth factor) and PI3K inhibitors (LY294002, wortmannin).
  • Assessed protein and mRNA levels of HIF-1alpha and HIF-1beta using Western blotting and other molecular techniques.
  • Employed reporter gene assays to measure vascular endothelial growth factor (VEGF) activity.

Main Results:

  • PI3K signaling, stimulated by insulin or EGF, specifically increased HIF-1alpha protein levels, but not HIF-1beta.
  • PI3K inhibitors LY294002 and wortmannin dose-dependently blocked this increase in HIF-1alpha.
  • Restoration of PTEN in PTEN-deficient cells reduced HIF-1alpha protein levels.
  • PI3K activation did not significantly alter HIF-1alpha mRNA levels.
  • Insulin-induced VEGF reporter gene activity was dependent on PI3K signaling and HIF-1 activity.

Conclusions:

  • PI3K signaling pathway activation is a key regulator of HIF-1alpha protein stability in cancer cells.
  • This regulation occurs post-transcriptionally, affecting protein levels rather than mRNA.
  • Targeting the PI3K pathway may offer a strategy to inhibit HIF-1alpha and downstream targets like VEGF in cancer therapy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...